Dermatologic Adverse Events | List of Frontiers open access articles

Review

Published on 28 Jul 2020

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

in Neuro-Oncology and Neurosurgical Oncology

Mario E. Lacouture
Milan J. Anadkat
Matthew T. Ballo
Fabio Iwamoto
Suriya A. Jeyapalan
Renato V. La Rocca
Margaret Schwartz
Jennifer N. Serventi
Martin Glas

Frontiers in Oncology

doi 10.3389/fonc.2020.01045

24,127 views
63 citations

Mini Review

Published on 13 Jun 2022

High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer

in Dermatology

Alyce M. Kuo
Alina Markova

Frontiers in Medicine

doi 10.3389/fmed.2022.898790

12,925 views
26 citations

Original Research

Published on 14 May 2025

Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database

in Pharmacoepidemiology

Yuan-Yuan Wu
Qiong-Lian Huang
Zhan-Yang Luo
Xiao-Yun Song
You-Yang Shi
Jin-Zhou Zheng
Sheng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529342

4,198 views
3 citations

Systematic Review

Published on 22 Jul 2021

Differential Dermatologic Adverse Events Associated With Checkpoint Inhibitor Monotherapy and Combination Therapy: A Meta-Analysis of Randomized Control Trials

in Pharmacology of Anti-Cancer Drugs

Yang Ge
Huiyun Zhang
Nathaniel Weygant
Jiannan Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2021.640099

3,187 views
5 citations

Review

Published on 04 Jan 2023

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region

in Thoracic Oncology

Milan J. Anadkat
Mario Lacouture
Adam Friedman
Zachary D. Horne
Jae Jung
Benjamin Kaffenberger
Sujith Kalmadi
Liza Ovington
Rupesh Kotecha
Huda Ismail Abdullah

Frontiers in Oncology

doi 10.3389/fonc.2022.975473

11,179 views
18 citations

Case Report

Published on 11 Jan 2024

Case report: Apalutamide-induced severe lethal cutaneous adverse effects in China

in Cancer Immunity and Immunotherapy

Qi Wang
Huali Cao
Xuetong Zhang
Huifeng Wu
Zhuangli Tang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1291564

4,195 views
12 citations

Articles